Dingxin Capital
Shenzhen, Guangdongdingxin-capital.com
Overview
Dingxin Capital is a venture capital and private equity firm founded in 2014. It focuses on early-stage investments in the healthcare and hard technology sectors, including TMT, biotechnology, and semiconductors. The firm's core team has a background in finance, healthcare, semiconductors, and communications. The firm is an active investor and is a member of the Shenzhen Venture Capital Association.
Portfolio Companies
13
Website
dingxin-capital.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Suzhou Otovia Therapeutics Co., Ltd. | Jan 2026 | VC Round | Co-investor |
| Nanjing Novlead Biotechnology | Apr 2025 | Series C | Lead |
| Shanghai Golden Leaf Med Tech Co., Ltd. | Mar 2024 | Series D | Co-investor |
| 广州南砂晶圆半导体技术有限公司 | Jul 2023 | VC Round | Co-investor |
| Suzhou Legendsemi Technology Co., Ltd. | Jun 2023 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
